The Latest

• August 20, 2020

  By Charleston Lim

  Johnson & Johnson Buying Momenta Pharmaceuticals For $6.5 Billion In Cash

  Momenta deal will enhance Johnson & Johnson unit’s lead in autoimmune diseases, it says.

  

  Momenta deal will enhance Johnson & Johnson unit’s lead in autoimmune diseases, it says.